Squamous cell carcinoma in epidermolysis bullosa. Treatment with systemic chemotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2205357.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dystrophic epidermolysis bullosa is associated with a high incidence of cutaneous squamous cell carcinoma. Despite aggressive surgical treatment, metastases occur frequently, and survival is generally poor. Chemotherapy for advanced disease has usually been avoided because of the potential for severe cutaneous toxicity. Two patients with autosomal recessive dystrophic epidermolysis bullosa and advanced squamous cell carcinoma are described. Both received cisplatin-based systemic chemotherapy without significant toxicity.
Medical subject headings
- Carcinoma, Squamous Cell
- Epidermolysis Bullosa
- Skin Neoplasms